Semnur Pharmaceuticals, Inc. SEC filings SMNRW
Semnur Pharmaceuticals, Inc. has 221 filings in SEC EDGAR's recent list, going back to Mar 1, 2022. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 7, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jul 7, 2026 | — |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 424B3 | Prospectus | Jun 15, 2026 | — |
| 424B3 | Prospectus | Jun 15, 2026 | — |
| POS AM | Filing | May 12, 2026 | — |
| 424B3 | Prospectus | Dec 29, 2025 | — |
| S-1/A | Amended registration statement | Dec 19, 2025 | — |
| S-8 | Employee stock plan registration | Dec 3, 2025 | — |
| S-8 | Employee stock plan registration | Dec 3, 2025 | — |
| S-1 | Registration statement | Oct 21, 2025 | — |
| 424B3 | Prospectus | Aug 13, 2025 | — |
| S-4/A | Filing | Aug 12, 2025 | — |
| S-4/A | Filing | Aug 11, 2025 | — |
| S-4/A | Filing | Aug 8, 2025 | — |
| S-4/A | Filing | Jul 23, 2025 | — |
| S-4/A | Filing | Jul 2, 2025 | — |
| S-4/A | Filing | Jun 11, 2025 | — |
| S-4/A | Filing | Apr 21, 2025 | — |
| S-4 | Registration for a merger or exchange | Nov 6, 2024 | — |
| 424B3 | Prospectus | Apr 7, 2022 | — |
| S-1/A | Amended registration statement | Apr 5, 2022 | — |
| S-1/A | Amended registration statement | Mar 28, 2022 | — |
| S-1/A | Amended registration statement | Mar 22, 2022 | — |
| S-1 | Registration statement | Mar 1, 2022 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SMNR (OTC), SMNRW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1913577
- Former names
- Denali Capital Acquisition Corp. (until Sep 23, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.